Remineralization effect of CPP-ACP and fluoride for white spot lesions in vitro.

Remineralization effect of CPP-ACP and fluoride for white spot lesions in vitro.
复制标题

DOI:
10.1016/j.jdent.2014.09.004
复制
发表时间:
2014-12
影响因子:
4.4
通讯作者:
Wright T
Wright T
中科院分区:
医学2区
文献类型:
--
作者:
Oliveira GM;Ritter AV;Heymann HO;Swift E Jr;Donovan T;Brock G;Wright T

文献摘要

参考文献

被引文献

相似文献

This in vitro study compared the remineralization effect on white spot lesions of casein phosphopeptide-amorphous calcium phosphate crème, or CPP-ACP (MI Paste™), 1.1% NaF dentifrice containing 5000 ppm of fluoride (ControlRX™), or CPP-ACP crème with 900 ppm of fluoride (MI Paste Plus™) with that of a control. Artificial white spot lesions were created on smooth enamel surfaces of sound molars using a previously reported demineralization model. Specimens were randomly assigned to four treatments (n=35) with a pH-cycling model over 30 days: Control (no treatment); MI Paste (10% CPP-ACP crème); F5000 (1.1% NaF dentifrice); or MI Paste Plus (10% CPP-ACP plus 900 ppm fluoride crème). Products were applied following manufacturers’ directions. Changes in mean lesion depth expressed by percent fluorescence loss (∆F%), and lesion area (mm2) from baseline to after treatment were measured with light-induced fluorescence (QLF). Mean values of each parameter were compared between groups (p<0.05). The remineralization pattern for the F5000 group was unique with marked initial remineralization during the first 10 days and little subsequent change. Based on mean lesion area, the F5000 demonstrated greater remineralization than Control, MI Paste and MI Paste Plus groups. Based on mean fluorescence loss, the F5000 group showed improved remineralization relative to MI Paste Plus, but did not differ statistically from the Control at the end of 30 days. The 1.1% NaF dentifrice demonstrated overall greater remineralization ability than 10% CPP-ACP crème. However, the 1.1% NaF dentifrice was only as effective as the Control to reduce fluorescence loss.
DOI: 10.1074/jbc.m413504200
发表时间: 2005-04-15
影响因子: 4.8
作者:
Cross, KJ;Huq, NL;Reynolds, EC
通讯作者: Reynolds, EC
DOI: 10.1093/ejo/cjm008
发表时间: 2007-06-01
影响因子: 2.6
作者:
Mattousch, T. J. H.;van der Veen, M. H.;Zentner, A.
通讯作者: Zentner, A.
DOI: 10.1159/000262032
发表时间: 1995-01-01
期刊: CARIES RESEARCH
影响因子: 4.2
作者:
DEJONG, EDJ;SUNDSTROM, F;ANGMARMANSSON, B
通讯作者: ANGMARMANSSON, B
DOI: 10.1159/000113161
发表时间: 2008-01-01
期刊: CARIES RESEARCH
影响因子: 4.2
作者:
Cochrane, N. J.;Saranathan, S.;Reynolds, E. C.
通讯作者: Reynolds, E. C.
DOI: 10.1177/10454411930040031401
发表时间: 1993-01-01
期刊: CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE
影响因子: --
作者:
FEATHERSTONE, JDB;BEHRMAN, JM;BELL, JE
通讯作者: BELL, JE